MMikrobiomik Healthcare Company — Seed (estimated) · €1.6M
A €1.6M capital increase came mostly from existing shareholders. Three new investors joined: two Spanish family offices and a business angel from the global pharmaceutical industry. The money was meant to expand manufacturing capacity for MBK-01, grow the team and speed up the pipeline. The CaixaBank CIB-advised €6-10M strategic round launched in 2024 was never reported as closed.
Lead unknown
RoundSeed (estimated)
AnnouncedMar 2025
CityDerio
SectorHealthtech & Bio · Biotech / Microbiome therapeutics
Source
M
M
The company
Investors
No investors were disclosed for this round.